Models
AMANTA HEALTHCARE LIMITEDAMANTAPharmaceuticals & Biotechnology
₹10per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model₹10implied FY26 P/E 2.5× · EV/EBITDA 3.4×
Against CMP ₹197.75−94.8%close of 2026-09-10
Growth the CMP implies45.0%revenue, a year for 5 years, on your other inputs
Value after FY31133%share of enterprise value in the terminal
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.
Where the methods land · ₹ per share · the dashed line is the CMP
DCF, rate ±1 · growth ±1your model across the sensitivity grid
₹(9)₹49
52-week rangetraded range, a fact not a value
₹92₹210
From enterprise to equity · ₹ crore
| PV of FY27–FY31 free cash flow | (63) |
| PV of terminal value | 256 |
| Enterprise value | 193 |
| less net debt | (153) |
| less non-controlling interest | 0 |
| add non-operating investments | 0 |
| Equity value | 40 |
| ÷ 3.88 crore shares | ₹10 |
133% of the value sits after FY31. Usual when return on capital sits near the cost of capital; the 5 explicit years carry little of it.
Free cash flow, filed and modelled · ₹ '000 crore
Filed, cash from operations − capexModelled free cash flow to firm
Sensitivity · ₹ per share
Down Across| WACC ↓terminal growth → | 4.0% | 4.5% | 5.0% | 5.5% | 6.0% |
|---|---|---|---|---|---|
| 10.00% | 13 | 19 | 27 | 37 | 49 |
| 10.50% | 6 | 11 | 18 | 26 | 35 |
| 11.00% | 0 | 5 | 10 | 17 | 24 |
| 11.50% | (5) | (1) | 4 | 9 | 15 |
| 12.00% | (9) | (5) | (2) | 3 | 8 |
The outlined cell is your model. Green figures sit above the CMP of ₹197.75; n/a marks a terminal growth at or above the discount rate. Steps: WACC and terminal growth ±0.5 point, growth ±2, margin ±1.
Distribution of outcomes · 4,000 draws · growth, margin and the discount rate vary together
| 10th · 50th · 90th percentile, ₹ per share | (13) · 10 · 34 |
| Draws below the CMP | 100% |
| Rank correlation with ebitda margin | +0.89 |
| Rank correlation with discount rate | −0.40 |
| Rank correlation with revenue growth | −0.10 |
Each driver is drawn from a PERT distribution between the lowest and highest value across your scenarios (or ±50% growth, ±20% margin when there is one scenario), with the discount rate ±1.5 points. Seeded, so the same inputs give the same picture.
Projected cash flow to the firm · ₹ crore
History Forward| ₹ crore | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 |
|---|---|---|---|---|---|---|
| Revenue | 288 | 311 | 336 | 362 | 391 | 423 |
| growth % | — | 8.0 | 8.0 | 8.0 | 8.0 | 8.0 |
| EBITDA | 57 | 62 | 67 | 72 | 78 | 84 |
| margin % | 19.9 | 19.9 | 19.9 | 19.9 | 19.9 | 19.9 |
| less depreciation | (19) | (20) | (22) | (24) | (25) | (27) |
| EBIT | 38 | 42 | 45 | 49 | 52 | 57 |
| less tax on EBIT | (11) | (12) | (13) | (14) | (16) | (17) |
| NOPAT | 27 | 29 | 32 | 34 | 37 | 40 |
| add depreciation | 19 | 20 | 22 | 24 | 25 | 27 |
| less capex | (80) | (87) | (77) | (65) | (50) | (33) |
| less working-capital build | — | (7) | (8) | (8) | (9) | (10) |
| Free cash flow to firm | — | (44) | (31) | (15) | 3 | 25 |
| Discount factor | 0.949 | 0.855 | 0.770 | 0.694 | 0.625 | |
| Present value | (42) | (27) | (12) | 2 | 15 |
History columns are the filed years (free cash flow there is cash from operations − capex, as filed); the base year and everything to its right come from the engine. Forward is the explicit horizon of the model itself: 3, 5 or 10 years, then flat.
The three statements, projected · ₹ crore · debt held at 234, dividends at 2.7% of profit
| ₹ crore | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| EBIT | 38 | 42 | 45 | 49 | 52 | 57 |
| Interest at 8.8% on debt | (21) | (21) | (21) | (21) | (21) | |
| Profit before tax | 21 | 24 | 28 | 32 | 36 | |
| Profit after tax | 15 | 15 | 17 | 20 | 22 | 25 |
| Dividends | (0) | (0) | (0) | (1) | (1) | (1) |
| Balance sheet, year end | ||||||
| Cash | 81 | 22 | (24) | (55) | (67) | (57) |
| Working capital | 90 | 97 | 105 | 113 | 122 | 132 |
| Net block and other assets | 387 | 454 | 509 | 550 | 574 | 580 |
| Debt | 234 | 234 | 234 | 234 | 234 | 234 |
| Equity | 220 | 235 | 251 | 270 | 292 | 317 |
| Balance check | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow | ||||||
| From operations | 28 | 31 | 35 | 39 | 43 | |
| Investing (capex) | (87) | (77) | (65) | (50) | (33) | |
| Financing (dividends) | (0) | (0) | (1) | (1) | (1) | |
| Net change in cash | (59) | (46) | (30) | (12) | 9 | |
| Free cash flow to equity | (59) | (46) | (30) | (11) | 10 | |
Other liabilities are held at their FY26 level, so the check tests only what the model moves: cash, working capital, net block and other assets, debt and equity. A non-zero check would mean the three statements no longer tie.
Scenarios side by side · ₹ per share
| Scenario | Template | Growth | Margin | Rate | Terminal | ₹ / share | vs CMP |
|---|---|---|---|---|---|---|---|
| Base · editing | DCF | 8% | 19.9% | 11.00% | 5% | ₹10 | (94.8)% |
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.